Oracle (ORCL) option IV elevated into quarter results

Go back to Oracle (ORCL) option IV elevated into quarter results

Oracle (ORCL) PT Raised to $189 at CFRA

December 10, 2024 10:06 AM UTC

CFRA analyst Angelo Zino raised the price target on Oracle (NYSE: ORCL) to $189.00 (from $172.00) while maintaining a Hold rating.

The analyst comments "We lift our 12-month target to $189 from $172, applying the same forward P/E of 25x but shifting to our CY 26 EPS... More

Oracle (ORCL) PT Raised to $200 at Evercore ISI

December 10, 2024 5:18 AM UTC

Evercore ISI analyst Kirk Materne raised the price target on Oracle (NYSE: ORCL) to $200.00 (from $190.00) while maintaining a Outperform rating.

The analyst comments "Bottom line: Oracle delivered solid F2Q results and we believe the pullback in the shares today has a lot more to do with some profit taking after a big move in the shares YTD vs. any real change in the outlook when thinking out to CY25. An incremental ~2% headwind... More